Abbott Laboratories (ABT)
Healthcare
Medical Devices
105.70 $
+0.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns Abbott Laboratories (ABT)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 99.4% of the shares are freely tradable; institutional investors hold 82.7%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
82.7%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.5%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
99.4%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
1.6%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
1,730Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| BlackRock Inc | 8.42 | 145,687,458 | -0.8 | 03/31/2026 |
| Vanguard Capital Management, LLC | 6.53 | 112,949,933 | +0.0 | 03/31/2026 |
| State Street Corp | 4.60 | 79,575,468 | -0.3 | 03/31/2026 |
| Capital Research Global Investors | 2.88 | 49,775,362 | +27.1 | 03/31/2026 |
| Vanguard Portfolio Management, LLC | 2.77 | 47,944,891 | +0.0 | 03/31/2026 |
| Charles Schwab Investment Management Inc | 2.63 | 45,500,055 | +245.0 | 03/31/2026 |
| Geode Capital Management, LLC | 2.26 | 39,148,795 | +1.9 | 03/31/2026 |
Funds
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| Vanguard Morn Total Stk Mkt Idx Investor | 3.20 | 55,306,751 | +0.0 | 06/30/2026 |
| Schwab US Dividend Equity ETF™ | 2.63 | 45,594,332 | +0.1 | 07/29/2026 |
| Vanguard 500 Index Investor | 2.61 | 45,247,066 | -0.6 | 06/30/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.